|
1
|
Prossler J, Chen Q, Chamley L and James
JL: The relationship between TGFβ, low oxygen and the outgrowth of
extravillous trophoblasts from anchoring villi during the first
trimester of pregnancy. Cytokine. 68:9–15. 2014.
|
|
2
|
Genest DR, Berkowitz RS and Fisher RA:
Gestational trophoblastic disease. World Health Organization
Classification of Tumours, Pathology and Genetics Tumours of the
Breast and Female Genital Organs. Tavassoli FA and Devilee P: 4.
3rd edition. IARC Press; Lyon: pp. 250–254. 2003
|
|
3
|
Knöfler M: Critical growth factors and
signalling pathways controlling human trophoblast invasion. Int J
Dev Biol. 54:269–280. 2010.
|
|
4
|
Lunghi L, Ferretti ME, Medici S, et al:
Control of human trophoblast function. Reprod Biol Endocrinol.
5:62007.
|
|
5
|
Simpson H, Robson SC, Bulmer JN, et al:
Transforming growth factor beta expression in human placenta and
placental bed during early pregnancy. Placenta. 23:44–58. 2002.
|
|
6
|
Graham CH, Lysiak JJ, McCrae KR and Lala
PK: Localization of transforming growth factor-beta at the human
fetal-maternal interface: role in trophoblast growth and
differentiation. Biol Reprod. 46:561–572. 1992.
|
|
7
|
Lysiak JJ, Hunt J, Pringle GA and Lala PK:
Location of transformationg growth factor beta and its natural
inhibitor decorin in the human placenta and deciduas throughout
gestation. Placenta. 16:221–231. 1995.
|
|
8
|
Graham CH and Lala PK: Mechanism of
control of trophoblast invasion in situ. J Cell Physiol.
148:228–234. 1991.
|
|
9
|
Zhen FA, Ying-Yong L, Guang CY and Jun LY:
Effect and significance of TGF-β1 on cell proliferation of human
first trimester cytotrophoblasts and JAR cells. MCHCC.
18:2582–2585. 2008.(In Chinese).
|
|
10
|
Lala PK and Chakraborty C: Factors
regulating trophoblast migration and invasiveness: possible
derangements contributing to pre-eclampsia and fetal injury.
Placenta. 24:575–587. 2003.
|
|
11
|
Zhao MR, Qiu W, Li YX, et al: Dual effect
of transforming growth factor beta1 on cell adhesion and invasion
in human placenta trophoblast cells. Reproduction. 132:333–341.
2006.
|
|
12
|
Graham CH, Hawley TS, Hawley RG, et al:
Establishment and characterization of first trimester human
trophoblast cells with extended lifespan. Exp Cell Res.
206:204–211. 1993.
|
|
13
|
Shi Y and Massagué J: Mechanisms of
TGF-beta signaling from cell membrane to the nucleus. Cell.
113:685–700. 2003.
|
|
14
|
Kaminska B, Kocyk M and Kijewska M: TGF
beta signaling and its role in glioma pathogenesis. Adv Exp Med
Biol. 986:171–187. 2013.
|
|
15
|
Petroff MG, Phillips TA, Ka H, et al:
Isolation and culture of term human trophoblast cells. Methods Mol
Med. 121:203–217. 2006.
|
|
16
|
Suzuki T, Higgins PJ and Crawford DR:
Control selection for RNA quantitation. Biotechniques. 29:332–337.
2000.
|
|
17
|
Sundqvist A, Ten Dijke P and van Dam H:
Key signaling nodes in mammary gland development and cancer: Smad
signal integration in epithelial cell plasticity. Breast Cancer
Res. 14:2042012.
|
|
18
|
Collet C, Laplanche JL and de Vernejoul
MC: Camurati-Engelmann disease with obesity in a newly identified
family carrying a missense p.Arg156Cys mutation in the TGFB1 gene.
Am J Med Genet A. 161A:2074–2077. 2013.
|
|
19
|
Lv ZD, Kong B, Li JG, et al: Transforming
growth factor-β 1 enhances the invasiveness of breast cancer cells
by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Oncol Rep. 29:219–225. 2013.
|
|
20
|
Lee D, Chung YH, Kim JA, et al:
Transforming growth factor beta 1 overexpression is closely related
to invasiveness of hepatocellular carcinoma. Oncology. 82:11–18.
2012.
|
|
21
|
Dave H, Shah M, Trivedi S and Shukla S:
Prognostic utility of circulating transforming growth factor beta 1
in breast cancer patients. Int J Biol Markers. 27:53–59. 2012.
|
|
22
|
Dehaghani AS, Rad NR, Fattahi MJ, et al:
Investigation of soluble HER2 and transforming growth factor Beta-1
serum levels in gestational trophoblastic disease. Pathol Oncol
Res. 15:37–40. 2009.
|
|
23
|
Khoo NK, Bechberger JF, Shepherd T, et al:
SV40 Tag transformation of the normal invasive trophoblast results
in a premalignant phenotype. I. Mechanisms responsible for
hyperinvasiveness and resistance to anti-invasive action of
TGFbeta. Int J Cancer. 77:429–439. 1998.
|
|
24
|
Khoo NK, Zhang Y, Bechberger JF, Bond SL,
Hum K and Lala PK: SV40 Tag transformation of the normal invasive
trophoblast results in a premalignant phenotype. II. Changes in gap
junctional intercellular communication. Int J Cancer. 77:440–448.
1998.
|
|
25
|
Guo RF, Zang SZ, Zhang L, et al: Relations
of transforming growth factor-beta1 expression to differentiation
and prognosis of advanced gastric cancer. Zhonghua Yi Xue Za Zhi.
86:3249–3254. 2006.(In Chinese).
|
|
26
|
Huang CH, Tseng WY, Yao CC, et al:
Glucosamine promotes osteogenic differentiation of dental pulp stem
cells through modulating the level of the transforming growth
factor-beta type I receptor. J Cell Physiol. 225:140–151. 2010.
|
|
27
|
Chegini N, Luo X, Ding L and Ripley D: The
expression of Smads and transforming growth factor beta receptors
in leiomyoma and myometrium and the effect of gonadotropin
releasing hormone analogue therapy. Mol Cell Endocrinol. 209:9–16.
2003.
|
|
28
|
Yang G and Yang X: Smad4-mediated TGF-beta
signaling in tumorigenesis. Int J Biol Sci. 6:1–8. 2010.
|
|
29
|
Brown KA, Pietenpol JA and Moses HL: A
tale of two proteins: differential roles and regulation of Smad2
and Smad3 in TGF-beta signaling. J Cell Biochem. 101:9–33.
2007.
|
|
30
|
Leng A, Liu T, He Y, et al: Smad4/Smad7
balance: a role of tumorigenesis in gastric cancer. Exp Mol Pathol.
87:48–53. 2009.
|
|
31
|
Chen QX, Shao BY, Zheng H, et al:
Expression and significance of TGF-B1 and its intracellular
signaling molecules SMAD4, SMAD7 in human glioma. Chin J Exp Surg.
1:90–92. 2005.
|
|
32
|
Lu B, Zhou YN, Li Q, et al: Correlations
of TGF-betaRII, Smad4 and Smad7 expression to clinicopathologic
characteristics and prognosis of gastric cancer. Ai Zheng.
28:538–542. 2009.
|
|
33
|
Schiller M, Javelaud D and Mauviel A:
TGF-beta-induced SMAD signaling and gene regulation: consequences
for extracellular matrix remodeling and wound healing. J Dermatol
Sci. 35:83–92. 2004.
|
|
34
|
Mori Y, Chen SJ and Varga J: Modulation of
endogenous Smad expression in normal skin fibroblasts by
transforming growth factor-beta. Exp Cell Res. 258:374–383.
2000.
|
|
35
|
Nakao A, Okumura K and Ogawa H: Smad7: a
new key player in TGF-beta-associated disease. Trends Mol Med.
8:361–363. 2002.
|
|
36
|
Kleeff J, Ishiwata T, Maruyama H, et al:
The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in
pancreatic cancer. Oncogene. 18:5363–5372. 1999.
|
|
37
|
Huo YY, Zhang KT, Li BY, et al: Regulation
of Smad7 gene by TGF-beta 1 in the process of malignant
transformation. Ai Zheng. 21:117–121. 2002.(In Chinese).
|
|
38
|
Bischof P, Meisser A and Campana A:
Paracrine and autocrine regulators of trophoblast invasion - a
review. Placenta. 21(Suppl A): S55–S60. 2000.
|
|
39
|
Burns JS, Abdallah BM, Guldberg P, et al:
Tumorigenic heterogeneity in cancer stem cells evolved form
long-term cultures of telomerase-immortalized human mesenchymal
stem cells. Cancer Res. 65:3126–3135. 2005.
|
|
40
|
Hai C, Jun D, Xi-Chuan Y, et al: Genetic
stability of immortal melanocytes transfected by SV40T antigen gene
[J]. Practical Journal of Clinical Medicine. 5:24–27. 2008.
|
|
41
|
Ahuja D, Sáenz-Robles MT and Pipas JM:
SV40 large T antigen targets multiple cellular pathways to elicit
cellular transformation. Oncogene. 24:7729–7745. 2005.
|
|
42
|
Bosticardo M, Ghosh A, Du Y, et al:
Self-inactivating retroviral vector-mediated gene transfer induces
oncogene activation and immortalization of primary murine bone
marrow cells. Mol Ther. 17:1910–1918. 2009.
|
